Reuters logo
2 months ago
BRIEF-Quantum Genomics announces design of its next phase II trial in arterial hypertension
June 28, 2017 / 6:03 AM / 2 months ago

BRIEF-Quantum Genomics announces design of its next phase II trial in arterial hypertension

June 28 (Reuters) - QUANTUM GENOMICS SA:

* QUANTUM GENOMICS ANNOUNCES THE DESIGN OF ITS NEXT PHASE II TRIAL IN ARTERIAL HYPERTENSION, NEW-HOPE

* AT END OF THIS TRIAL - RESULTS OF WHICH ARE EXPECTED IN FIRST HALF OF 2019 - A PHASE III CLINICAL TRIAL COULD THEN BE INITIATED WITH QGC001. SOURCE TEXT FOR EIKON: FURTHER COMPANY COVERAGE: (Gdynia Newsroom:)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below